LCC Reviewers Required

The ‘Let’s Communicate Cancer’ working group have a great opportunity for pharmacists to become involved in the review of the ‘Let’s communicate cancer’ training modules.

 

‘Let’s communicate cancer’ is an extensive resource for all health professionals on many aspects of cancer care. The resource includes information on cancer prevention, diagnosis, treatments, and how to better support patients undergoing cancer treatment. Of the five training modules, four will need to be reviewed in the current update:

 

  • Module 1: Early diagnosis and prevention
  • Module 2: What is cancer
  • Module 3: Treatment of cancer
  • Module 4: Supporting your patients with cancer

 

Who are we looking for?

 

For the update, we are looking for a number of experienced pharmacists to review the eLearning content which includes PowerPoint presentations, quizzes, PDFs and videos. If you have a minimum of 3 years’ experience practicing in oncology, or alternatively, if you are a community pharmacist with an interest in oncology we would love to hear from you.

 

How to apply?

 

If you would like to get involved please send us a brief statement (roughly 300 words) of the skills and experience you have which would be beneficial in the review of the modules. Please also include your current role and place of work.

Applications should be sent to [email protected]. Please note, applications will close on 29th March 2024 and we will let candidates know the outcome by 22nd April 2024.

 

Thank you!

We understand everyone is under increased pressure at the moment and the reviewer will be remunerated for their valuable time. We aim to have the review completed by the end of May.

Thank you for considering this opportunity and we look forward to hearing from you!

 

Best wishes,

Jackie Lewis and Jennifer McClintick

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article